[go: up one dir, main page]

CL2006002332A1 - Metodo para preparar una composicion medica que comprende preparar una composicion para tratamiento y agregar al menos un agente a dicha composicion, en donde los agentes tienen la propiedad de aumentar o al menos mantener la viscosidad de la composi - Google Patents

Metodo para preparar una composicion medica que comprende preparar una composicion para tratamiento y agregar al menos un agente a dicha composicion, en donde los agentes tienen la propiedad de aumentar o al menos mantener la viscosidad de la composi

Info

Publication number
CL2006002332A1
CL2006002332A1 CL200602332A CL2006002332A CL2006002332A1 CL 2006002332 A1 CL2006002332 A1 CL 2006002332A1 CL 200602332 A CL200602332 A CL 200602332A CL 2006002332 A CL2006002332 A CL 2006002332A CL 2006002332 A1 CL2006002332 A1 CL 2006002332A1
Authority
CL
Chile
Prior art keywords
composition
preparing
viscosity
agents
maintaining
Prior art date
Application number
CL200602332A
Other languages
English (en)
Inventor
Charles Molan Peter
Original Assignee
Comvita Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37836076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2006002332(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Comvita Ltd filed Critical Comvita Ltd
Publication of CL2006002332A1 publication Critical patent/CL2006002332A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CL200602332A 2005-09-06 2006-09-06 Metodo para preparar una composicion medica que comprende preparar una composicion para tratamiento y agregar al menos un agente a dicha composicion, en donde los agentes tienen la propiedad de aumentar o al menos mantener la viscosidad de la composi CL2006002332A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ542258A NZ542258A (en) 2005-09-06 2005-09-06 A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds

Publications (1)

Publication Number Publication Date
CL2006002332A1 true CL2006002332A1 (es) 2008-02-22

Family

ID=37836076

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200602332A CL2006002332A1 (es) 2005-09-06 2006-09-06 Metodo para preparar una composicion medica que comprende preparar una composicion para tratamiento y agregar al menos un agente a dicha composicion, en donde los agentes tienen la propiedad de aumentar o al menos mantener la viscosidad de la composi

Country Status (11)

Country Link
US (1) US20090148537A1 (es)
EP (1) EP1933858A4 (es)
JP (1) JP2009507069A (es)
CN (1) CN101277709A (es)
AR (1) AR056500A1 (es)
AU (1) AU2006288017B2 (es)
CA (1) CA2621774A1 (es)
CL (1) CL2006002332A1 (es)
NZ (1) NZ542258A (es)
PE (1) PE20070525A1 (es)
WO (1) WO2007030023A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0813541D0 (en) * 2008-07-24 2008-08-27 Brightwake Ltd Honey wound dressing
CA2748232A1 (en) * 2008-12-24 2010-07-22 Comvita New Zealand Limited Medical and nutritional formulations
WO2011139168A1 (en) * 2010-05-05 2011-11-10 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
AU2013202889B2 (en) * 2010-05-05 2014-09-18 Comvita New Zealand Limited A method of determining the immunostimulatory properties of a honey or honey analogue
ITRM20120555A1 (it) * 2012-11-13 2014-05-14 Aboca Spa Societa Agricola Enteroclismi.
CA2922955C (en) 2013-09-02 2020-09-22 Honeylab Limited Honey compositions
US10342891B2 (en) 2013-09-19 2019-07-09 Medline Industries, Inc. Wound dressing containing saccharide and collagen
US10086017B2 (en) 2013-09-19 2018-10-02 Medline Industries, Inc. Wound dressing containing polysaccharides
GB2535666B (en) 2014-04-30 2017-03-29 Matoke Holdings Ltd Antimicrobial compositions
CN106692190A (zh) * 2017-01-25 2017-05-24 天津嘉氏堂科技有限公司 一种具有创面修护作用的组合物及制备方法
GB2566951A (en) * 2017-09-27 2019-04-03 Brightwake Ltd Compositions for wound treatment
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
AU2020299505B2 (en) * 2019-07-04 2022-06-16 Comvita Limited Use of a composition comprising 3,6,7-trimethyllumazine for preventing, ameliorating or treating MMP-9 associated conditions and inflammation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827561C1 (es) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5078313A (en) * 1990-07-11 1992-01-07 Sweetheart Cup Company Inc. Wax-coated paperboard containers
JP3583166B2 (ja) * 1994-06-27 2004-10-27 興和株式会社 損傷皮膚修復用粉末製剤
WO2001006788A1 (en) * 1999-07-16 2001-01-25 United Video Properties, Inc. Interactive television program guide with selectable languages
USRE42755E1 (en) * 1999-12-09 2011-09-27 Apimed Medical Honey Limited Honey based wound dressing
WO2001067888A1 (en) * 2000-03-17 2001-09-20 Phillip Roy Caskey Improvements in and relating to honey based products
NL1016398C2 (nl) * 2000-10-13 2002-04-16 Triticum Exploitatie B V Samenstelling op basis van een therapeutisch actieve verbinding, in het bijzonder honing, voor het behandelen van wonden.
GB0110715D0 (en) * 2001-05-02 2001-06-27 Acordis Speciality Fibres Ltd Wound dressing
WO2005077402A1 (en) * 2004-02-11 2005-08-25 Virchow Biotech Private Limited Honey based gel formulations

Also Published As

Publication number Publication date
WO2007030023A1 (en) 2007-03-15
CA2621774A1 (en) 2007-03-15
JP2009507069A (ja) 2009-02-19
AU2006288017A1 (en) 2007-03-15
PE20070525A1 (es) 2007-07-13
NZ542258A (en) 2010-05-28
AR056500A1 (es) 2007-10-10
AU2006288017B2 (en) 2012-04-19
EP1933858A1 (en) 2008-06-25
EP1933858A4 (en) 2009-09-30
CN101277709A (zh) 2008-10-01
US20090148537A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0916235A2 (pt) composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
BRPI0821299A2 (pt) Composto, processo para preparar o mesmo, composição farmacêutica, processo para preparar a mesma, uso de um composto, e, método para tratar, ou reduzir o risco de, uma doença ou condição.
CL2008001619A1 (es) Suplemento dietetico que comprende por lo menos un agente condroprotector y por lo menos un quelato metalico; y metodo para fomentar el alivio del dolor,crecimiento,reparacion y/o mantencion de huesos y/o tejido de las articulaciones en un mamifero por medio de dicho suplemento.
HN2006000971A (es) Metodos para preparar composiciones o formas de dosificacion que comprenden un agonista grp119 que tiene el efecto de un secretagogo glp-1
CL2007003245A1 (es) Composicion farmaceutica en capa que comprende dos o mas capas farmaceuticas y al menos una capa intermedia dispuesta entre al menos dos o mas capas, donde la capa intermedia es configurada para disolverse in vivo donde dichas dos capas farmaceuticas
CL2006002332A1 (es) Metodo para preparar una composicion medica que comprende preparar una composicion para tratamiento y agregar al menos un agente a dicha composicion, en donde los agentes tienen la propiedad de aumentar o al menos mantener la viscosidad de la composi
CR11731A (es) Composiciones y procedimientos para su preparación y uso
CL2014000732A1 (es) Compuestos derivados heterociclicos para su uso en la prevencion o tratamiento de una infeccion por flavivirus; metodo para su preparacion; y composicion farmaceutica que los comprende.
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
BRPI0811317A2 (pt) Combinação, embalagem farmcêutica, kit ou mbalagem par apaciente, agente auxiliar, compsoto, usos de um agente auxiliar e de um composto, e, processo para a produção de uma combinação
AR054227A1 (es) Composicion de principios activos
CL2013001436A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
CR8766A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
BRPI0717697A2 (pt) composto, composição farmaceutica, uso do composto, método para tratar um paciente sofrendo de uma condição patológica ou uma doença e combinação de produtos
BRPI0917705A2 (pt) composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
AR109263A2 (es) Composición que comprende moxidectina
BRPI0717753A2 (pt) Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
BRPI0907976A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0814811A2 (pt) Composto, agente, método, e composição de diagnóstico, uso de um composto, e, método de formação de imagem
CL2007003331A1 (es) Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente.
CL2007002026A1 (es) Composicion que comprende al menos un compuesto quelante de hierro y al menos un agente antifungico; y metodo para el tratamiento o prevencion de una condicion fungica.
CL2007002371A1 (es) Metodo para administrar un agente terapeutico que comprende administrar una composicion de nanoparticulas que comprende una matriz polimerica junto con un cation divalente que contiene un agente terapeutico; y dicha composicion.
AR071183A1 (es) Composicion oral que comprende un componente activo y un componente formador de pelicula adhesiva, metodo